TherapeuticsMD, Inc.·4

Aug 30, 9:49 PM ET

Krassan Mitchell 4

4 · TherapeuticsMD, Inc. · Filed Aug 30, 2019

Insider Transaction Report

Form 4
Period: 2019-08-28
Krassan Mitchell
EVP, Chief Strategy Officer
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2019-08-28+300,000300,000 total
    Exercise: $2.73From: 2020-08-28Exp: 2029-08-28Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]Underlying shares vest as follows: 100,000 shares on the first anniversary date of the grant, 100,000 shares on the second anniversary date of the grant, and 100,000 shares on the third anniversary date of the grant.

Documents

1 file
  • 4
    ownership.xmlPrimary

    OWNERSHIP DOCUMENT